16 Jun 2021

New study on Māori, Pasifika, elderly response to Covid-19 vaccine

From Checkpoint, 6:19 pm on 16 June 2021

A clinical study getting underway in Rotorua and Christchurch will provide valuable information on how our the population responds to the Pfizer-BioNTech Covid-19 vaccine.

The study aims to enrol at least 300 adult participants with a focus on Maori, Pasifika, adults 65 years old and older, and those with co-morbidities associated with increased risk of Covid-19.

The study will assess immune responses for up to 12 months after the last vaccine dose.

Sela Jane Hopgood delves into what the study entails.